4//SEC Filing
Huang Alan 4
Accession 0000899243-22-004603
CIK 0001819133other
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 4:30 PM ET
Size
9.9 KB
Accession
0000899243-22-004603
Insider Transaction Report
Form 4
Huang Alan
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-02-01+200,000→ 200,000 totalExercise: $9.22Exp: 2032-02-01→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a four-year period, at a rate of 25% on January 1, 2023, with the remaining option shares vesting in 36 equal monthly installments thereafter.
Issuer
Tango Therapeutics, Inc.
CIK 0001819133
Entity typeother
Related Parties
1- filerCIK 0001877364
Filing Metadata
- Form type
- 4
- Filed
- Feb 2, 7:00 PM ET
- Accepted
- Feb 3, 4:30 PM ET
- Size
- 9.9 KB